{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:19:08Z","timestamp":1791551948836,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jhep.2014.11.024","type":"journal-article","created":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T20:32:27Z","timestamp":1417033947000},"page":"841-847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease"],"prefix":"10.1016","volume":"62","author":[{"given":"Mariana","family":"Lazo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne M.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Coresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.C.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiadi","family":"Ndumele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron C.","family":"Hoogeveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie M.","family":"Ballantyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Selvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2014.11.024_b0005","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jhep.2012.03.019","article-title":"A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France","volume":"57","author":"Ratziu","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.11.024_b0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-0028-1091978","article-title":"The epidemiology of non-alcoholic fatty liver disease: a global perspective","volume":"28","author":"Lazo","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2014.11.024_b0015","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/hep.23784","article-title":"Clinical, laboratory and histological associations in adults with non-alcoholic fatty liver disease","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.11.024_b0020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.11.024_b0025","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.23527","article-title":"The incidence and risk factors of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis","volume":"51","author":"Ascha","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.11.024_b0030","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.510290347","article-title":"Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease","volume":"29","author":"Caldwell","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.11.024_b0035","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1001\/jama.289.22.3000","article-title":"Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis","volume":"289","author":"Clark","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2014.11.024_b0040","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.11.024_b0045","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1185\/03007995.2010.506375","article-title":"Population-based risk factors and resource utilization for HCC: US perspective","volume":"26","author":"Sanyal","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jhep.2014.11.024_b0050","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00125-008-1135-4","article-title":"Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?","volume":"51","author":"Targher","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.jhep.2014.11.024_b0055","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/hep.23789","article-title":"Liver enzymes, non-alcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data","volume":"52","author":"Ghouri","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.11.024_b0060","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.numecd.2007.01.007","article-title":"Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question","volume":"17","author":"Loria","year":"2007","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jhep.2014.11.024_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20070311","article-title":"Is liver fat detrimental to vessels? Intersections in the pathogenesis of NAFLD and atherosclerosis","volume":"115","author":"Loria","year":"2008","journal-title":"Clin Sci"},{"key":"10.1016\/j.jhep.2014.11.024_b0070","doi-asserted-by":"crossref","first-page":"e837","DOI":"10.1161\/CIRCULATIONAHA.111.077602","article-title":"Ectopic fat depots and cardiovascular disease","volume":"124","author":"Britton","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2014.11.024_b0075","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-0028-1091981","article-title":"Mechanisms of disease progression in non-alcoholic fatty liver disease","volume":"28","author":"Jou","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2014.11.024_b0080","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with non-alcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.11.024_b0085","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1056\/NEJMoa0707064","article-title":"Use of multiple biomarkers to improve the prediction of death from cardiovascular causes","volume":"358","author":"Zethelius","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.11.024_b0090","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1001\/jama.2010.1768","article-title":"Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population","volume":"304","author":"de Lemos","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2014.11.024_b0095","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1161\/CIRCULATIONAHA.110.005264","article-title":"Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study","volume":"123","author":"Saunders","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2014.11.024_b0100","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1001\/jama.2010.1708","article-title":"Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults","volume":"304:","author":"deFilippi","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2014.11.024_b0105","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa0805299","article-title":"A sensitive cardiac troponin T assay in stable coronary artery disease","volume":"361","author":"Omland","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.11.024_b0110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/hrt.2003.026021","article-title":"Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population","volume":"90","author":"Groenning","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.jhep.2014.11.024_b0115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejheart.2003.12.015","article-title":"Essential biochemistry and physiology of (NT-pro)BNP","volume":"6","author":"Hall","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jhep.2014.11.024_b0120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.HYP.28.1.22","article-title":"Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension","volume":"28","author":"Nishikimi","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.jhep.2014.11.024_b0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jama.297.2.169","article-title":"N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease","volume":"297","author":"Bibbins-Domingo","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2014.11.024_b0130","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(97)06031-5","article-title":"Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care","volume":"350","author":"Cowie","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2014.11.024_b0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.amjcard.2007.11.014","article-title":"Amino-terminal pro-B-type natriuretic peptides: testing in general populations","volume":"101","author":"de Lemos","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jhep.2014.11.024_b0140","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa042330","article-title":"N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease","volume":"352","author":"Kragelund","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.11.024_b0145","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejheart.2004.01.010","article-title":"NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies","volume":"6","author":"McDonagh","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jhep.2014.11.024_b0150","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.HYP.0000216794.24161.8c","article-title":"Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure","volume":"47","author":"McKie","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.jhep.2014.11.024_b0155","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","article-title":"The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators","volume":"129","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jhep.2014.11.024_b0160","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1373\/clinchem.2010.159350","article-title":"Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study","volume":"57","author":"Agarwal","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.jhep.2014.11.024_b0165","unstructured":"ARIC Study protocol. Manual 7: Blood Collection and Processing."},{"key":"10.1016\/j.jhep.2014.11.024_b0170","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.gastro.2008.10.052","article-title":"Elevated serum alanine aminotransferase and gamma-glutamyl transferase and mortality in the United States population","volume":"136","author":"Ruhl","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.11.024_b0175","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1161\/CIRCULATIONAHA.105.552547","article-title":"Gamma-glutamyl transferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults","volume":"112","author":"Ruttmann","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2014.11.024_b0180","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1161\/ATVBAHA.107.152298","article-title":"Gamma-glutamyl transferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women\u2019s Heart and Health Study and Meta-Analysis","volume":"27","author":"Fraser","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jhep.2014.11.024_b0185","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/ije\/dyr172","article-title":"The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes","volume":"40","author":"Ford","year":"2011","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jhep.2014.11.024_b0190","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2008.06.012","article-title":"Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review","volume":"49","author":"Sookoian","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.11.024_b0195","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1515\/CCLM.2010.349","article-title":"Relationship of hepatic steatosis and alanine aminotransferase with coronary calcification","volume":"48","author":"Jung","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jhep.2014.11.024_b0200","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.atherosclerosis.2007.01.026","article-title":"Hepatic steatosis is associated with a greater prevalence of coronary artery calcification in asymptomatic men","volume":"194","author":"Santos","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jhep.2014.11.024_b0205","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/0003-4819-144-7-200604040-00011","article-title":"Adiposity of the heart, revisited","volume":"144","author":"McGavock","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2014.11.024_b0210","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCULATIONAHA.106.645614","article-title":"Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study","volume":"116","author":"McGavock","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2014.11.024_b0215","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0032-1306426","article-title":"Obstructive sleep apnea-hypopnea syndrome and non-alcoholic fatty liver disease: emerging evidence and mechanisms","volume":"32","author":"Musso","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2014.11.024_b0220","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tem.2007.11.006","article-title":"Control of lipolysis by natriuretic peptides and cyclic GMP","volume":"19","author":"Lafontan","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jhep.2014.11.024_b0225","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.2337\/db09-0393","article-title":"Natriuretic peptides\/cGMP\/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity","volume":"58","author":"Miyashita","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2014.11.024_b0230","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1172\/JCI62595","article-title":"NPs \u2013 heart hormones that regulate brown fat?","volume":"122","author":"Whittle","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.11.024_b0235","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/CIRCULATIONAHA.105.555573","article-title":"Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study","volume":"112","author":"Das","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2014.11.024_b0240","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.0000112582.16683.EA","article-title":"Impact of obesity on plasma natriuretic peptide levels","volume":"109","author":"Wang","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2014.11.024_b0245","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.2337\/db13-0478","article-title":"N-terminal pro-brain natriuretic peptide and risk of diabetes","volume":"62","author":"Lazo","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2014.11.024_b0250","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ejheart.2005.10.018","article-title":"Non-cardiac determinants of NT-proBNP levels in the elderly: relevance of haematocrit and hepatic steatosis","volume":"8","author":"Muscari","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jhep.2014.11.024_b0255","first-page":"e240","article-title":"ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"2013","author":"Writing Committee","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2014.11.024_b0260","doi-asserted-by":"crossref","first-page":"348","DOI":"10.7326\/0003-4819-148-5-200803040-00005","article-title":"Brief communication: clinical implications of short-term variability in liver function test results","volume":"148","author":"Lazo","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2014.11.024_b0265","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/dme.12187","article-title":"Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"30","author":"Schneider","year":"2013","journal-title":"Diabet Med"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814008733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814008733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T07:51:13Z","timestamp":1538034673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827814008733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0168827814008733"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2014.11.024","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2014.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}